|
|
|
ITC Maratha, Mumbai, India
Apr 13 2012 8:30AM - Apr 14 2012 5:00PM
Pharmaceutical manufacturers in India are facing many challenges within the domestic and global regulatory environment. These challenges include manufacturing and quality control, testing and packaging. This conference will provide interactive sessions on many of these issues including discussion on strategies to achieve global regulatory compliance. FEATURED TOPICS • Focus on Recent Changes in EU, US and Emerging Market’s Regulatory Landscape • Complex Generics—Regulator’s Role in Driving the Agenda • Evolving Biosimilar Regulation in India and Overseas • Drug Regulatory Affairs—Profession and Career • Quality Assurance and Compliance • Quality by Design—Guiding Principles in Drug Development Leading to Robust Regulatory Submission • Regulatory Operations—CTD and Beyond • Pharmacovigilance
All attendees will receive a DIA Certificate of Attendance at the conclusion of the event Event Code: 12651
|
|
|
|
|
|
Organized by:
|
|
DIA India |
|
Invited Speakers:
|
|
KEYNOTE SPEAKER Rajiv Malik COO and Executive Vice President Mylan Inc., USA INTERNATIONAL SPEAKERS Arun Mishra Director- Global Regulatory Affairs, Emerging Markets and Asia Pacific GlaxoSmithKline Paul EllisDirector, External Advocacy GlaxoSmithKline, UK Dr Adnan MahmoodClinical Research Physician Janssen Pharmaceutical Companies, J & J Dr Alberto Grignolo Corporate Vice President Global Strategy PAREXEL Consulting
|
|
|
|
|
|
Deadline for Abstracts:
|
|
Call contact
|
|
|
|
|
|
Registration:
|
|
MEETING MANAGER: Manoj Trivedi, Senior Manager Marketing and Program Development, DIA (India) Private Limited Cell: +91.98.1977.7493, Tel: +91.22.6765.3226 email: Manoj.Trivedi@diaindia.org
|
|
E-mail:
|
|
manoj.trivedi@diaindia.org
|
|
|
|
|
|
|
|